Reduced cytokine levels among people living with HIV (PLWH) in ghana co-infected with human coronaviruses.

Publication date: Jul 16, 2026

Cytokines play crucial roles in regulating immune cell interactions, and in influencing innate and adaptive immune responses. People living with HIV (PLWH) on antiretroviral therapy (ART) show reduced inflammation and immune activation but with partial immune recovery. Interactions between HIV and human coronaviruses (hCoVs), with respect to immune modulation and ART impact on immune recovery, are not well understood. In this case-control cross-sectional study, we investigated cytokine profiles among three groups: PLWH co-infected with hCoVs (HIV+/hCoVs+), HIV mono-infected individuals (HIV+/hCoVs-), and HIV-negative without hCoVs control group (HIV-/hCoVs). A total of 300 PLWH were screened for hCoVs in three hospitals by subjecting their nasopharyngeal and oropharyngeal swabs to RNA extraction and PCR. Sixty-seven (67) PLWH with hCoVs were age- and sex-matched with HIV mono-infected and HIV negative control groups, and plasma samples were collected to assess cytokine levels using a Luminex multiplex bead-based immunoassay. Lower cytokine levels were observed among the HIV co-infected and mono-infected groups compared to HIV-negative control group. Granzyme B, TNF-α, IL-17 A, IL-3, IL-15 and VEGF were significantly reduced in the HIV co-infected group. Participants who had been on ART for less than a year had higher TNF-α levels than those who had been on ART for more than 5 years. The study demonstrates that HIV co-infection with hCoVs is associated with significantly reduced levels of key cytokines, which may be due to immune dysregulation and/or exhaustion associated with chronic HIV infections. The cytokine phenotype may be mitigated with long-term ART, which reduces inflammation and promote immunological recovery.

Open Access PDF

Concepts Keywords
Cytokines
Human coronaviruses
Human immunodeficiency virus

Semantics

Type Source Name
disease MESH inflammation
disease MESH co-infection
disease MESH HIV infections
pathway REACTOME Reproduction
disease MESH included
disease MESH ILs
disease MESH infection
disease MESH autoimmune diseases
disease MESH viral infections
pathway KEGG Viral replication
disease MESH cytokine storm
disease MESH death
pathway REACTOME HIV Infection
disease MESH pneumonia
disease MESH coronavirus infection
pathway REACTOME Apoptosis
drug DRUGBANK Cycloserine
disease MESH DCs
drug DRUGBANK Aspartame
drug DRUGBANK Pentaerythritol tetranitrate
drug DRUGBANK Abacavir
drug DRUGBANK Lamivudine
drug DRUGBANK Dolutegravir
drug DRUGBANK Tenofovir disoproxil
drug DRUGBANK Zidovudine
drug DRUGBANK Nevirapine
disease MESH COVID 19
pathway REACTOME Immune System
disease MESH immune suppression
disease MESH aids
disease MESH ALD
drug DRUGBANK Edetic Acid
drug DRUGBANK Water
drug DRUGBANK Biotin
disease MESH Alcohol Abuse
pathway KEGG Alcoholism
drug DRUGBANK Isoxaflutole
pathway REACTOME Signal Transduction
disease MESH severe acute respiratory syndrome
disease MESH CSd
disease MESH common cold
drug DRUGBANK Glutathione
drug DRUGBANK Carboxyamidotriazole
disease MESH infectious diseases
drug DRUGBANK (S)-Des-Me-Ampa
disease MESH acute respiratory distress syndrome
drug DRUGBANK Muplestim
disease MESH influenza
disease MESH Lord
disease MESH pathological processes
disease MESH hepatitis
drug DRUGBANK Spinosad
drug DRUGBANK Efavirenz
disease MESH Dis
disease MESH thoracic disease
drug DRUGBANK Proline

Original Article

(Visited 5 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *